SCHEMBL17890294

SCHEMBL17890294

COc1cc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc(OC)c1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 1.00
▸ MEN1 O00255 7/20 0.72
▸ PSMD14 O00487 1/20 0.72
▸ ABL1 P00519 1/20 0.68
▸ LCK P06239 1/20 0.68
▸ LYN P07948 1/20 0.68
▸ SRC P12931 1/20 0.68
▸ CSK P41240 1/20 0.68
▸ BTK Q06187 1/20 0.68
▸ PTK6 Q13882 1/20 0.68
▸ NPC1 O15118 8/20 0.68
▸ RAB9A P51151 8/20 0.68
▸ TUBB4A P04350 5/20 0.67
▸ TUBB P07437 5/20 0.67
▸ TUBA3C P0DPH7 5/20 0.67
▸ TUBA1B P68363 5/20 0.67
▸ TUBA4A P68366 5/20 0.67
▸ TUBB4B P68371 5/20 0.67
▸ TUBB3 Q13509 5/20 0.67
▸ TUBB2A Q13885 5/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17890297 1.00 KMT2A (1.00) KMT2AMEN1PSMD14ABL1LCK
SCHEMBL6230728 0.88 KMT2A (0.82) KMT2AMEN1PSMD14ABL1LCK
SCHEMBL6230731 0.88 KMT2A (0.82) KMT2AMEN1PSMD14ABL1LCK
SCHEMBL17890024 0.81 TUBB4A (0.77) KMT2AMEN1PSMD14ABL1LCK
SCHEMBL17890026 0.81 TUBB4A (0.77) KMT2AMEN1PSMD14ABL1LCK
SCHEMBL1508832 0.80 TUBB4A (1.00) KMT2AMEN1NPC1RAB9ATUBB4A
SCHEMBL1508835 0.80 TUBB4A (1.00) KMT2AMEN1NPC1RAB9ATUBB4A
SCHEMBL6977895 0.77 PSEN1 (1.00) KMT2AMEN1PSMD14NPC1RAB9A
SCHEMBL16017996 0.77 GUSB (0.76) KMT2ANPC1RAB9ACASP3SENP7
SCHEMBL10684960 0.77 KMT2A (0.62) KMT2AMEN1PSMD14TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9951029-B2 Styryl quinazoline derivatives as pharmaceutically active agents VICHEM CHEMIE KUTATÓ KFT. (HU) 2018-04-24 — — US disclosed
US-20160194291-A1 STYRYL QUINAZOLINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE AGENTS VICHEM CHEMIE KUTATÓ KFT. (HU) 2016-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194291-A1 STYRYL QUINAZOLINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE AGENTS FLT3, BCR, STK3 KMT2A 3110/4885MEN1 3840/4885PSMD14 4120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback